Valeritas Holdings (VLRX) Starts Presentation at LD Micro Main Event
Valeritas Holdings (OTC: VLRX) is a commercial-stage medical technology company focused on developing innovative technologies to improve the health and quality of life of people with Type 2 diabetes. The company's flagship product, the V-Go® Disposable Insulin Delivery device, is a simple, wearable, basal-bolus, insulin delivery solution for patients with Type 2 diabetes that enables the administration of a continuous preset basal rate infusion of insulin over 24 hours. For more information, visit the company's website at www.valeritas.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As…